Anti-tumoral effect of the mitochondrial target domain of Noxa delivered by an engineered Salmonella typhimurium.
about
Targeted Cancer Therapy Using Engineered Salmonella typhimuriumImpediments to enhancement of CPT-11 anticancer activity by E. coli directed beta-glucuronidase therapyAnti-tumor activity of an immunotoxin (TGFα-PE38) delivered by attenuated Salmonella typhimuriumPotent and tumor specific: arming bacteria with therapeutic proteins.Salmonella typhimurium Suppresses Tumor Growth via the Pro-Inflammatory Cytokine Interleukin-1β.L-Asparaginase delivered by Salmonella typhimurium suppresses solid tumorsEngineering Salmonella as intracellular factory for effective killing of tumour cells.Tumor-targeted delivery of a C-terminally truncated FADD (N-FADD) significantly suppresses the B16F10 melanoma via enhancing apoptosis.Improved cytotoxic effects of Salmonella-producing cytosine deaminase in tumour cells.Salmonella-Mediated Cancer Therapy: Roles and Potential.Local application of bacteria improves safety of Salmonella -mediated tumor therapy and retains advantages of systemic infection.Activation of inflammasome by attenuated Salmonella typhimurium in bacteria-mediated cancer therapy.Proteus mirabilis inhibits cancer growth and pulmonary metastasis in a mouse breast cancer model.Engineered Salmonella enterica serovar Typhimurium overcomes limitations of anti-bacterial immunity in bacteria-mediated tumor therapy.Two-step enhanced cancer immunotherapy with engineered Salmonella typhimurium secreting heterologous flagellin.Cell mass-dependent expression of an anticancer protein drug by tumor-targeted Salmonella.
P2860
Q28069354-E4218707-D89D-4C61-B13C-8A25DCBD25DFQ28543432-CB27117E-D8FB-4D03-A18A-FF76AB75DB2DQ33914020-7D31414B-FB85-42BC-BE3F-EE1D9A65BA4BQ35579375-E556FFDC-2CD3-4F08-83E8-16BD6A84C9FBQ36191597-1C3C77CA-F05D-4568-BC99-E5E8D096DB75Q36838520-1DD139FC-79C5-4BF4-8EE5-608324D1E4A9Q37134828-838D220D-E64F-4AE0-8FA5-434C11FCBC51Q37355548-33083B7A-A34D-4248-9561-3AD843FF6F48Q38955988-2835B9C3-5B99-4063-A575-97D50762205CQ39339432-2EC0F759-1177-4E86-867B-AE45BAFA18E2Q40163572-E5C43A0F-69EF-4AA3-9BE2-EE4E79C8FC66Q40937873-45DD90C3-DBE1-4CD4-8EAE-DE5C8BDED00FQ46247736-C93D4153-0E00-4C56-9135-3940774C9162Q47195461-A7D3A450-E385-4C30-BD98-1E9D80DC6FFEQ47587450-843E6578-4A45-41F7-B789-C161ADF80EB5Q50317370-D9E362FF-F4D2-4167-A562-DC61A76DD931
P2860
Anti-tumoral effect of the mitochondrial target domain of Noxa delivered by an engineered Salmonella typhimurium.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Anti-tumoral effect of the mit ...... neered Salmonella typhimurium.
@en
Anti-tumoral effect of the mit ...... neered Salmonella typhimurium.
@nl
type
label
Anti-tumoral effect of the mit ...... neered Salmonella typhimurium.
@en
Anti-tumoral effect of the mit ...... neered Salmonella typhimurium.
@nl
prefLabel
Anti-tumoral effect of the mit ...... neered Salmonella typhimurium.
@en
Anti-tumoral effect of the mit ...... neered Salmonella typhimurium.
@nl
P2093
P2860
P1433
P1476
Anti-tumoral effect of the mit ...... neered Salmonella typhimurium.
@en
P2093
Daejin Lim
Geun-Joong Kim
Hyon E Choy
Jae Il Kim
Jae-Ho Jeong
Jeong-A Lim
Jung-Joon Min
Kwangjoon Jeong
Kwangsoo Kim
Sangryeol Ryu
P2860
P304
P356
10.1371/JOURNAL.PONE.0080050
P407
P577
2014-01-08T00:00:00Z